Advertisement
New Zealand markets close in 1 hour 3 minutes
  • NZX 50

    12,445.04
    -85.96 (-0.69%)
     
  • NZD/USD

    0.5919
    -0.0014 (-0.24%)
     
  • NZD/EUR

    0.5458
    -0.0010 (-0.18%)
     
  • ALL ORDS

    8,107.90
    -97.60 (-1.19%)
     
  • ASX 200

    7,874.90
    -88.80 (-1.12%)
     
  • OIL

    76.96
    -0.63 (-0.81%)
     
  • GOLD

    2,373.80
    -41.90 (-1.73%)
     
  • NASDAQ

    19,032.39
    -721.91 (-3.65%)
     
  • FTSE

    8,153.69
    -13.68 (-0.17%)
     
  • Dow Jones

    39,853.87
    -504.23 (-1.25%)
     
  • DAX

    18,387.46
    -170.24 (-0.92%)
     
  • Hang Seng

    17,064.33
    -246.72 (-1.43%)
     
  • NIKKEI 225

    37,960.29
    -1,194.56 (-3.05%)
     
  • NZD/JPY

    90.1910
    -0.9230 (-1.01%)
     

More Likely to 5x First: Novavax vs. Ocugen

More Likely to 5x First: Novavax vs. Ocugen

Biotech companies are ripe with innovation. The two stocks I'll talk about here -- Novavax (NASDAQ: NVAX) and Ocugen (NASDAQ: OCGN) -- both have soared in recent years on optimism about potentially game-changing products. Novavax soared more than 2,700% in 2020 as investors bet on its investigational coronavirus vaccine.